QUBIPANNCT07868120
Brain Iron in Beta-Propeller Protein Associated Neurodegeneration (BPAN)
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Brain Iron
Timeframe: Baseline (T0), month 18 (T18).
Secondary (1)
Correlation between intracerebral iron levels and clinical symptom severity
Arms and interventions
Patients with genetically confirmed BPANExperimental
Each participant will be followed for 18 months, with two main study visits (baseline and 18 months). Clinical and imaging data will be collected at each visit as part of routine care and study procedures. Additional visits may occur if clinically indicated
Other: Standardized brain MRI including specific sequences usable for Quantitative Susceptibility Mapping (QSM)
Sites
1 site in 1 country
- CHU de BordeauxBordeaux, France